🔗 Visit the ClinicalTrials.gov page for NCT00047073
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. | PLoS Med | 2008 | 5.54 |
| 2 | The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. | PLoS Med | 2008 | 2.79 |
| 3 | Targeting protein kinases in central nervous system disorders. | Nat Rev Drug Discov | 2009 | 1.45 |
| 4 | PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. | Oncotarget | 2016 | 1.02 |
| 5 | The mTOR signaling pathway as a treatment target for intracranial neoplasms. | Neuro Oncol | 2014 | 0.84 |